Real-life anticoagulants benefit-risk in atrial fibrillation (AF) in France: VKA benefit-risk assessment before DOAC use for AF (ENGEL 1 VKA) First published 23/05/2014 Last updated 23/07/2024 EU PAS number:EUPAS6616 Study Finalised